/ Not yet recruitingPhase 2 Randomized, double-blind, placebo-controlled clinical trial to evaluate the optimal dose of Beltavac® with polymerized extract of grass pollen mixture in patients with allergic rhinoconjunctivitis associated or not with asthma. - PRO RCT GRAM 2022
100 Clinical Results associated with Probelte Pharma, S.L.
0 Patents (Medical) associated with Probelte Pharma, S.L.
100 Deals associated with Probelte Pharma, S.L.
100 Translational Medicine associated with Probelte Pharma, S.L.